Friday, April 13, 2012
A step in the quest for CFIDS/ME biomarkers....
Found this in a June 2011 CFIDS newsletter. It is highly technical, but the results are fascinating:
Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
The more readily identifiable specific biomarkers become, the more useful they will be in diagnosing diseases. The sooner we figure out what a patient has, the sooner treatment can begin, and the greater the likelihood of limiting its severity and/or progression.
Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
The more readily identifiable specific biomarkers become, the more useful they will be in diagnosing diseases. The sooner we figure out what a patient has, the sooner treatment can begin, and the greater the likelihood of limiting its severity and/or progression.
Comments:
Post a Comment
